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In an attempt to form 2-alkylidene-1,3-oxazolidines, chiral 2-oxazolines have been N-alkylated and N-acylated. Two new N-
methyloxazolinium salts have been prepared and characterised but base treatment resulted in their decomposition. In contrast, attempts to 
isolate three N-benzoyloxazolinium salts gave the products of their ring hydrolysis: unsymmetrically diacylated amino alcohols whose 
structure was confirmed by x-ray diffraction in one case. Overall the method allows stepwise regiospecific N,O-diacylation of 1,2-amino 
alcohols. 
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We recently reported that the thermal isomerization of 2-
benzylidene-1,3-dioxolane (1) to give the γ-lactone 2 
(Scheme 1), which was previously carried out by gas-phase 
flow pyrolysis at atmospheric pressure,1 could be achieved 
more efficiently using conditions of flash vacuum pyrolysis 
(FVP).2 In the same paper 1,3-oxathiolane derivatives 
including the sulfone analogue of 1 were also examined but 
in these cases the pyrolysis took a different course.2 We 
were interested to examine the nitrogen analogues 3 since, 
if these reacted in the same way as 1, they would give the 
more useful γ-lactams 4 with the added advantage that a 
stereogenic centre at the 4-position in the starting 
oxazolidines would likely appear with  retention of 
configuration at C-5 in the product and induce 






We envisaged that the required 2-
alkylideneoxazolidines 7 could be prepared starting from 
the readily available oxazolines 5 by N-alkylation to give 
salts 6 followed by base treatment (Scheme 2). Literature 
precedent for this is provided by sodium hydride treatment 
of 2,3,4,4-tetramethyloxazolinium iodide to give the 2-
methylene compound,3 although this was noted to be 
extremely susceptible to acid-catalysed hydrolysis, a 
feature also observed for similar N-methyloxazolinium salts 






We started by converting the two readily available 
chiral oxazolines 5a and 5b, prepared by reaction of ethyl 
acetimidate hydrochloride with (S)-phenylalaninol and (S)-
valinol respectively,5 into the corresponding N-
methyloxazolinium salts 6a and 6b. Treatment with 
iodomethane in THF at room temperature in the dark gave 
the required salts in low to moderate yield as colourless 
crystals (Scheme 3). It was noticeable that the more 
sterically hindered compound 5b reacted more slowly and 
to give a lower yield of 6 than 5a. These gave the expected 
HRMS and spectroscopic properties including significant 
movement to higher chemical shift in the 1H NMR signals 
for the ring hydrogens and 2-methyl group as compared to 
the starting oxazolines. In the 13C NMR spectra the most 
prominent change was an increase in the chemical shift for 







































































Unfortunately, treatment of the salts 6 with sodium 
hydride in dry THF according to the literature method for 
the corresponding 4,4-dimethyl compounds,3 led, after 
addition of petroleum and removal of the resulting 
precipitate of sodium iodide, to solutions of compounds 7 
that were too reactive to handle using normal methods and 
polymerised. In order to obtain less reactive and more 
easily handled 2-alkylidene-1,3-oxazolidines 7, we decided 
to move to N-benzoyl oxazolinium salts (Scheme 4) since 
these are a well known class of stable compounds,6 and are 
reported to undergo facile deprotonation using 
triethylamine,7 although there are a number of possible 
complicating side-reactions of the 2-methylene-1,3-






Following the literature method,7 oxazoline 5a was 
stirred in toluene with one equivalent of triethylamine 
while one equivalent of benzoyl chloride was added 
dropwise. After 3 h the solution was filtered and evaporated 
to give, after trituration with diethyl ether, a solid that 












It seems likely that the desired N-benzoyloxazolinium 
salt has been formed but, rather than undergo deprotonation 
to form the alkylidene compound 7, it has undergone 
hydrolysis in the course of isolation to give the N-benzoyl-
O-acetylphenylalaninol product 8a. This compound was 
first prepared and characterised spectroscopically in 1992,9 
but it was recorded in the literature some time earlier10 as a 
derivative of N-benzoylphenylalaninol occurring as a 
natural product in the leaves of Alangium lamarckii. More 
recently it has been mentioned under the trivial name 
"saropeptate", together with a range of steroidal 
components, as a constituent of Pupalia lappacea, a plant 
important in Ayurvedic medicine.11 
Although compound 8a showed excellent agreement 
with the literature spectroscopic data,9 it was obtained in 
well-formed crystals so we took the chance to confirm its 
structure using X-ray diffraction (Figure 1). As might be 
expected, the presence of a secondary amide function leads 
to hydrogen bonding and the crystal structure shows chains 
of molecules formed by the amide carbonyl C(1)–O(1) to 
N(2)–H(2) hydrogen bonding (Figure 2, Table 1). 
 
 
Figure 1. Molecular structure of compound 8a with 
atoms represented by thermal vibration ellipsoids at the 






































































































Figure 2. Hydrogen bonding pattern in crystal structure 
of 8a viewed perpendicular to the a axis. 
 
Table 1. Hydrogen bonding parameters for 8a (Å, °) 
 
D—H...A D—H H...A D...A D—H...A 
N(2)–H(2)...O(1) 0.98(5) 1.94(5) 2.870(7) 157(6) 
 
Having established that hydrolysis of the N-
benzoyloxazolidinium salts rather than any base-induced 
process was involved in the formation of 8a, the oxazolines 
5b and 5c were subjected to reaction with benzoyl chloride 
in the absence of triethylamine and in each case the product 
recovered after evaporation and trituration was the 
hydrolysis product 8 (Scheme 5). Both N-benzoyl-O-
acetylvalinol 8b and N-benzoyl-O-phenylacetylphenylalan-
-inol 8c are apparently new compounds and gave 
spectroscopic data in good agreement with the proposed 
structures and with that of 8a. The 2-benzyloxazoline 5c 
took much longer to react than 2-methyloxazolines 5a and 
5b, presumably due to the electron-withdrawing phenyl 
group making it less nucleophilic. 
Although it has clearly been arrived at by accident 
rather than design, the overall formation of the selectively 
diacylated amino alcohols 8 starting from compounds of 
general structure 9 is a rather useful transformation. Recent 
studies have proposed various catalysts to bring about 
enzyme-like selectivity in such reactions.12 In this case the 
general method for overall conversion of an amino acid-
derived chiral amino alcohol 9 into the diacylated 
derivative 10 involves formation of the oxazoline 5 with 
the ultimate O-substituent at the 2-position, N-acylation 
with the ultimate N-substituent and hydrolytic isolation to 





In contrast to N-methyloxazolinium salts which were 
easily prepared and isolated, the N-benzoyloxazolinium 
salts proved to be much more reactive and could not be 
isolated as such. However the isolation of their hydrolysis 
products in low to moderate yield does form the basis of a 
useful overall synthetic transformation. 
EXPERIMENTAL 
General Experimental Details. Melting points were 
determined using a Gallenkamp 50W melting point 
apparatus and are uncorrected. IR spectra were measured 
using the ATR techique on a Shimadzu IRAffinity 1S 
instrument. NMR spectra were recorded on solutions in 
CDCl3 at 400 MHz for 1H and at 100 or 125 MHz for 13C 
using Bruker AV400 or AVIII 500 spectrometers. HRMS 
measurements were made using a Micromass LCT 
spectrometer with electrospray ionisation. THF was dried 
over sodium wire. 
Preparation of starting oxazolines. (S)-4-Benzyl-2-
methyloxazoline 5a and (S)-4-isopropyl-2-methyloxazoline 
5b were prepared from ethyl acetimidate hydrochloride by 
respective reaction with (S)-phenylalaninol and (S)-valinol 
as previously reported,5 while (S)-2,4-dibenzyloxazoline 5c 
was similarly prepared,13 using ethyl 2-phenylacetimidate 
hydrochloride14 and (S)-phenylalaninol. 
(S)-4-Benzyl-2,3-dimethyloxazolinium iodide (6a). A 
solution of oxazoline 5a (2.0 g, 11.4 mmol) in dry THF 
(2.5 ml) was stirred at room temperature while 
iodomethane (0.87 ml, 1.99 g, 14 mmol) was added and the 
resulting mixture was stirred in the dark for 15 h. The 
resulting solid was filtered off and dried. Yield 1.65 g 
(47%), colourless crystals, mp 176–178 °C. IR spectrum 
(ATR), ν, cm–1: 1668, 1483, 1279, 1033, 984, 758, 704. 1H 
NMR spectrum, δ, ppm (J, Hz): 2.59 (3H, s, 2-Me); 3.20 
(1H, half AB pattern of d, J = 14.4, J = 7.6, PhCH2); 3.35 
(1H, half AB pattern of d, J = 14.4, J = 4.8, PhCH2); 3.51 
(3H, s, 3-Me); 4.68 (1H, half AB pattern of d, J = 9.0, J = 
6.4, OCH2); 5.08–5.16 (1H, m, 4-H); 5.19 (1H, half AB 
pattern of d, J = 10.3, J = 9.0, OCH2); 7.23–7.27 (2H, m, 
Ph); 7.30–7.41 (3H, m, Ph). 13C NMR spectrum, δ, ppm: 
15.3 (2-Me); 34.5 (3-Me); 36.3 (PhCH2); 64.6 (4-CH); 75.4 
(CH2O); 128.1 (Ar CH); 129.1 (Ar 2CH); 129.4 (Ar 2CH); 
133.0 (Ar C); 176.7 (C-2). Found, m/z: 190.1224 [M–I]+. 
C12H16NO. Calculated, m/z: 190.1232. 
(S)-4-Isopropyl-2,3-dimethyloxazolinium iodide (6b). 
A solution of oxazoline 5b (1.40 g, 11.0 mmol) in dry THF 
(2.5 ml) was stirred at room temperature while 
iodomethane (0.87 ml, 1.99 g, 14 mmol) was added and the 
resulting mixture was stirred in the dark for 72 h. The 
resulting solid was filtered off and dried. Yield 0.69 g 
(23%), colourless crystals, mp 143–144 °C. IR spectrum 
(ATR), ν, cm–1: 1675, 1483, 1276, 1039, 987, 925, 830. 1H 
NMR spectrum, δ, ppm (J, Hz): 0.97 (3H, d, J = 6.9 
CHMe); 1.04 (3H, d, J = 6.9, CHMe); 2.32 (1H, m, 
CHMe2); 2.65 (3H, s, 2-Me); 3.44 (3H, s, 3-Me); 4.62 (1H, 
half AB pattern of d, J = 9.2, J = 6.8, OCH2); 4.70–4.80 
(1H, m, 4-H); 5.27 (1H, half AB pattern of d, J = 11.0, J = 
9.2, OCH2). 13C NMR spectrum, δ, ppm: 14.9 (CHMe); 
15.1 (CHMe); 17.9 (2-Me); 26.5 (CHMe2); 34.0 (3-Me); 
68.6 (4-CH); 72.0 (CH2O); 176.8 (C-2). Found, m/z: 

































(S)-2-Benzoylamino-3-phenylpropyl acetate (8a). A 
solution of oxazoline 5a (0.35 g, 2 mmol) and triethylamine 
(0.33 ml, 0.25 g, 2.4 mmol) in dry toluene (60 ml) was 
stirred at RT while benzoyl chloride (0.23 ml, 0.28 g, 2 
mmol) was added dropwise. After stirring for 3 h, the 
mixture was filtered and evaporated. The residue was 
triturated with diethyl ether to give the product. Yield 0.18 
g (31%), colourless crystals, mp 124–126 °C (lit.,9 125–127 
°C). 1H NMR spectrum, δ, ppm (J, Hz): 2.10 (3H, s, 
COMe); 2.91 (1H, half AB pattern of d, J = 13.6, J = 8.0, 
CH2Ph); 3.06 (1H, half AB pattern of d, J = 13.6, J = 5.8, 
CH2Ph); 4.14 (1H, half AB pattern of d, J = 11.6, J = 3.8, 
CH2O); 4.23 (1H, half AB pattern of d, J = 11.6, J = 6.0, 
CH2O); 4.60–4.70 (1H, m, CHNH); 6.41 (1H, br d, J = 8.0, 
NH); 7.20–7.30 (2H, m); 7.30–7.34 (3H, m); 7.40–7.45 
(2H, m); 7.48–7.52 (1H, m); 7.70–7.73 (2H, m). 13C NMR 
spectrum, δ, ppm: 20.9 (Me); 37.5 (CH2Ph); 50.3 (CHN); 
64.8 (CH2O); 126.8 (Ar 3CH); 128.6 (Ar 2CH); 128.7 (Ar 
2CH); 129.3 (Ar 2CH); 131.6 (Ar CH); 134.3 (Ar C); 136.9 
(Ar C); 167.0 (NCO); 171.5 (OCO). Both 1H and 13C NMR 
spectra showed excellent agreement with literature data.9 
X-ray structure of 8a. Crystal data: C18H19NO3, M = 
297.35, colourless needle, crystal dimensions 0.12 × 0.01 × 
0.01 mm, orthorhombic, space group P212121, a = 
5.0182(4), b = 16.208(3), c = 19.498(3) Å, V = 1585.9(4) 
Å3, Z = 4, Dc = 1.245 Mg m–3, T = 125 K, R = 0.1219, Rw = 
0.3082 for 1890 reflections with I>2σ(I) and 203 variables. 
Data were collected on a Rigaku XtaLAB P200 system 
using graphite-monchromated Cu-Kα radiation, λ = 1.54187 
Å and have been deposited at the Cambridge 
Crystallographic Data Centre as CCDC 1861267. The data 
can be obtained free of charge from the Cambridge 
Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/getstructures 
(S)-2-Benzoylamino-3-methylbutyl acetate (8b). A 
solution of oxazoline 5b (0.51 g, 4 mmol) in dry toluene 
(120 ml) was stirred at RT while benzoyl chloride (0.46 ml, 
0.56 g, 4 mmol) was added dropwise. After stirring for 3 h, 
the mixture was evaporated and the residue was triturated 
with diethyl ether to afford the title compound as colourless 
crystals (77 mg, 7%), mp 74–76 °C. 1H NMR spectrum, δ, 
ppm (J, Hz): 1.018 (3H, d, J = 6.8, CHMe); 1.022 (3H, d, J 
= 6.8, CHMe); 1.95 (1H, octet, J = 6.8, CHMe2); 2.06 (3H, 
s, COMe); 4.15 (1H, half AB pattern of d, J = 11.6, J = 3.6, 
CH2O); 4.20–4.30 (1H, m, CHNH); 4.39 (1H, half AB 
pattern of d, J = 11.6, J = 6.6, CH2O); 6.24 (1H, br d, J = 
8.4, NH); 7.40–7.60 (3H, m); 7.70–7.80 (2H, m). 13C NMR 
spectrum, δ, ppm: 18.7 (Me); 19.3 (Me); 20.9 (COMe); 
29.8 (CHMe2); 54.0 (CHN); 64.5 (CH2O); 126.8 (Ar 2CH); 
128.6 (Ar 2CH); 131.5 (Ar CH); 134.6 (Ar C); 167.3 
(NCO); 171.4 (OCO). Found, m/z: 250.1449 [M+H]+. 
C14H20NO3. Calculated, m/z: 250.1443. 
(S)-2-Benzoylamino-3-phenylpropyl phenylacetate 
(8c). A solution of oxazoline 5c (1.50 g, 6 mmol) in dry 
toluene (80 ml) was stirred at RT while benzoyl chloride 
(0.69 ml, 0.84 g, 6 mmol) was added dropwise. After 
stirring for 72 h, the mixture was evaporated and the 
residue was triturated with diethyl ether to afford the title 
compound (0.73 g, 31%) as colourless crystals, mp 122–
123 °C. IR spectrum (ATR), ν, cm–1: 3292, 1720, 1638, 
1537, 1263, 1152, 1011, 694. 1H NMR spectrum, δ, ppm 
(J, Hz): 2.79 (1H, half AB pattern of d, J = 13.6, J = 8.2, 
CH2Ph); 2.96 (1H, half AB pattern of d, J = 13.6, J = 5.8, 
CH2Ph); 3.67 (2H, s, COCH2Ph); 4.16 (1H, half AB pattern 
of d, J = 11.2, J = 4.0, CH2O); 4.21 (1H, half AB pattern of 
d, J = 11.2, J = 5.6, CH2O); 4.55–4.65 (1H, m, CHN); 6.19 
(1H, br d, J = 8.4, NH); 7.15 (2H, d, J = 8.0); 7.20–7.35 
(8H, m); 7.41 (2H, t, J = 8.0); 7.50 (1H, t, J = 7.0); 7.60 
(2H, d, J = 7.2). 13C NMR spectrum, δ, ppm: 37.4 (CH2Ph); 
41.5 (CH2Ph); 50.2 (CHN); 64.8 (CH2O); 126.8 (Ar 3CH); 
127.3 (Ar CH); 128.5 (Ar 2CH); 128.66 (Ar 2CH); 128.69 
(Ar 2CH); 129.2 (Ar 2CH); 129.3 (Ar 2CH); 131.6 (Ar 
CH); 133.8 (Ar C); 134.1 (Ar C); 136.8 (Ar C); 166.8 
(NCO); 171.7 (OCO). Found, m/z: 374.1745 [M+H]+. 
C24H24NO3. Calculated, m/z: 374.1756. 
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